about
In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii.Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.Listeriosis due to infection with a catalase-negative strain of Listeria monocytogenes.In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model.Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006Tackling antibiotic resistance: a dose of common antisense?Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans.Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6kb, class III, Bacteroides plasmid frequently found in clinical isolates from European countries.Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010.In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.A simple, semiselective medium for anaerobic isolation of anginosus group streptococci from patients with chronic lung disease.Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants.In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase.Herpes zoster.The dangers of dog bites.AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.Pneumonitis in an elderly Bangladeshi man.In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.Association of extended-spectrum β-lactamase VEB-5 and 16S rRNA methyltransferase armA in Salmonella enterica from the United Kingdom.Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii.Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii.Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
P50
Q33853213-22570EF5-3E13-49B5-AB0B-9C975985DE60Q34184603-5571B34F-F173-46D9-88D1-3F147546DB42Q34443982-9CEE2326-81B8-4695-A450-3838718555AEQ34680759-8ACC0488-5E58-4864-AC61-D42102F4ABE7Q36018796-27240069-258F-4833-8A2B-20593E235ADBQ36147517-C9EE7A99-1576-444F-91EF-901DDDBE8437Q36736995-B987CF2D-EB59-4D61-BDC7-9CFFE47D69F4Q37323966-B443B0F7-0D38-48AD-838C-9D31887B6E01Q37667216-D88CB257-78EC-43ED-8880-E066211AE178Q38149093-0A794B12-3882-46A2-9890-DF77087A4569Q39143298-4B509AFC-F564-4876-870B-DB5A1B69502CQ39412126-18091F34-F264-463B-B890-1CCC30383C44Q39582769-0CE91310-CDD0-4F18-A9BC-740E7E496B17Q39660131-B880067F-E570-4AF0-BB11-7486637132CFQ39912622-A156DFCE-1006-49E1-89C1-3C8292149B9AQ40322808-97C83514-9D13-4AD1-9F90-D2402130F418Q41056266-DF76CD1E-9C97-4123-AAEC-9FF35DC8A42BQ41077618-F3B052C2-BF5D-4621-B30F-7090BF003E6FQ41220559-8124C808-6B8F-492A-A98F-D9186F308FB6Q41625643-EBEF6103-4222-496C-AD5C-DB9F0E4516ACQ41763114-73F600C2-C1EE-4CB1-974D-3D5118487F6BQ41993199-85E24EE4-B2AC-449A-AC9E-041E07B2A7CFQ42003718-B15D3614-3C0E-4B24-9566-FCB023B7738AQ42010056-09EBAA99-AE3D-4716-A7A6-8E5B23F3D81DQ42248968-0E5B69BF-EA3C-4FDD-857F-EA30DB0AFB81Q42255874-626F555C-3674-4422-A969-03A2C64A14FCQ42265643-72918860-CF37-4602-A6DA-94C8B72F74A0Q42280134-0C3917D5-D087-4ACB-8ACB-3530AC8AF191Q42749667-36D44C76-CC89-4621-A987-491435D74957Q42834140-16F4C2FF-78ED-4C30-A5C1-17D332669A03Q43017225-6D8D75BF-2F75-4066-B33F-8DCDA69FE317Q43062402-8F225EFC-C815-448B-BDC0-97292E3B480AQ43080952-D6662FC1-E308-4C95-BD09-33243C180EC1Q43203255-B52C3823-8415-4160-A696-6707AFA1DFF3Q43243669-8D88B569-E130-4336-A464-35FF91C20190Q44492503-346AE1BB-8DCD-4A87-97C7-BEF9020FF1E3Q44959125-9015A103-9DF6-4AE4-B861-7546C545A7E2Q46091790-9048BC68-E14F-4674-8B2A-4DEC9DC7C461Q46213911-008E45D4-61FE-4A70-94DA-561697934B83Q46649253-96B5CDAA-8599-4C44-A31A-42731A959C71
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David W. Wareham
@ast
David W. Wareham
@en
David W. Wareham
@es
David W. Wareham
@nl
David W. Wareham
@sl
type
label
David W. Wareham
@ast
David W. Wareham
@en
David W. Wareham
@es
David W. Wareham
@nl
David W. Wareham
@sl
prefLabel
David W. Wareham
@ast
David W. Wareham
@en
David W. Wareham
@es
David W. Wareham
@nl
David W. Wareham
@sl
P106
P1153
7004167527
P21
P31
P496
0000-0003-4331-5224